Autopsy and Photon Counting Computed Tomography to Evaluate Thromboses Related to Central Venous Catheters

Recruiting Observational Study
Central Venous Catheter Thrombosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
75 (estimated)
Sponsor
Thomas Kander · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Central venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it was showed that 12 out of 12 deceased patients had subclinical CVK-related thrombosis (Rockholt et al.). To shed light on this problem, the current studies were designed. In sub-study 1, deceased patients with CVC who are referred for clini…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Substudy 1 Inclusion Criteria: * Diseased patients with an indwelling central venous catheter and a clinical indication for autopsy * Informed and signed consent from next of kind Exclusion Criteria: * None Substudy 2 Inclusion Criteria * Living patients with an indwelling central venous cathe…
Contacts

Thomas Kander, PhD

+4646171163

thomas.kander@med.lu.se

CONTACT

Emilia Ängeby Eriksson, MD

+4646175155

emilia.angeby@med.lu.se

CONTACT